Valneva (VALN) News Today $7.46 -0.45 (-5.69%) As of 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period HC Wainwright Cuts Valneva (NASDAQ:VALN) Price Target to $17.00February 21 at 2:55 AM | americanbankingnews.comKepler Capital Reaffirms Their Buy Rating on Valneva (0OB3)February 20 at 10:28 AM | markets.businessinsider.comHC Wainwright Issues Pessimistic Forecast for Valneva (NASDAQ:VALN) Stock PriceHC Wainwright reduced their price objective on Valneva from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday.February 20 at 8:05 AM | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - What's Next?Valneva (NASDAQ:VALN) Shares Gap Up - Time to Buy?February 19 at 9:53 PM | marketbeat.comValneva price target lowered to $17 from $18 at H.C. WainwrightFebruary 19 at 10:04 AM | markets.businessinsider.comValneva hits 2024 sales target but plans lower cash burn in 2025February 18 at 7:01 PM | finance.yahoo.comValneva Reports 2024 Financial Performance and Optimistic 2025 OutlookFebruary 18 at 9:11 AM | tipranks.comValneva Expects Further Sales GrowthFebruary 18 at 8:32 AM | marketwatch.comValneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 OutlookFebruary 18 at 1:00 AM | globenewswire.comValneva (NASDAQ:VALN) Stock Price Down 11.2% - What's Next?Valneva (NASDAQ:VALN) Stock Price Down 11.2% - Here's What HappenedFebruary 15, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?Valneva (NASDAQ:VALN) Shares Gap Down - Should You Sell?February 13, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - Still a Buy?Valneva (NASDAQ:VALN) Shares Gap Up - What's Next?February 13, 2025 | marketbeat.comValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's WhyValneva (NASDAQ:VALN) Sees Unusually-High Trading Volume - Here's What HappenedFebruary 12, 2025 | marketbeat.comValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedValneva (NASDAQ:VALN) Shares Gap Up - Here's What HappenedFebruary 11, 2025 | marketbeat.comValneva (NASDAQ:VALN) Stock Price Down 5.6% - Should You Sell?Valneva (NASDAQ:VALN) Trading Down 5.6% - Here's What HappenedFebruary 7, 2025 | marketbeat.comKepler Capital Sticks to Its Buy Rating for Valneva (0OB3)February 6, 2025 | markets.businessinsider.comShareholding declaration Valneva SE - January 2025February 6, 2025 | finance.yahoo.comValneva stock holds $18 target on UK vaccine nodFebruary 6, 2025 | msn.comValneva (NASDAQ:VALN) Stock Price Up 7.6% - What's Next?Valneva (NASDAQ:VALN) Shares Up 7.6% - Here's WhyFebruary 6, 2025 | marketbeat.comMHRA grants Valneva marketing authorization for chikungunya vaccineFebruary 5, 2025 | markets.businessinsider.comValneva jumps 19% after chikungunya vaccine wins UK approvalFebruary 5, 2025 | markets.businessinsider.comValneva’s chikungunya vaccine wins UK approvalFebruary 5, 2025 | finance.yahoo.comValneva rises after U.K. approval of chikungunya vaccineFebruary 5, 2025 | msn.comValneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®February 5, 2025 | markets.businessinsider.comValneva’s Chikungunya Vaccine Gains UK Approval, Expanding Global ReachFebruary 5, 2025 | tipranks.comValneva Receives Marketing Authorization in the UK for the World's First Chikungunya Vaccine, IXCHIQ®February 5, 2025 | globenewswire.comValneva (0OB3) Gets a Buy from Kepler CapitalFebruary 2, 2025 | markets.businessinsider.comShort Interest in Valneva SE (NASDAQ:VALN) Rises By 44.0%Valneva SE (NASDAQ:VALN - Get Free Report) was the target of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 22,900 shares, a growth of 44.0% from the December 31st total of 15,900 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 41,600 shares, the days-to-cover ratio is currently 0.6 days.January 31, 2025 | marketbeat.comValneva (NASDAQ:VALN) Earns "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $18.00 price objective on shares of Valneva in a report on Friday.January 31, 2025 | marketbeat.comValneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 MillionJanuary 30, 2025 | globenewswire.comValneva SE (NASDAQ:VALN) Sees Significant Drop in Short InterestValneva SE (NASDAQ:VALN - Get Free Report) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 15,900 shares, a drop of 34.6% from the December 31st total of 24,300 shares. Based on an average daily trading volume, of 38,300 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.0% of the company's stock are short sold.January 29, 2025 | marketbeat.comFY2024 Earnings Forecast for Valneva Issued By HC WainwrightValneva SE (NASDAQ:VALN - Free Report) - HC Wainwright lowered their FY2024 earnings per share (EPS) estimates for Valneva in a research report issued on Thursday, January 23rd. HC Wainwright analyst E. White now expects that the company will earn $0.13 per share for the year, down from their preJanuary 27, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Valneva Q1 Earnings?Valneva SE (NASDAQ:VALN - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Valneva in a research report issued to clients and investors on Thursday, January 23rd. HC Wainwright analyst E. White anticipates that the company will earn ($January 24, 2025 | marketbeat.comPositive Outlook for Valneva: Favorable Vaccine Trials and Expanding Market PotentialJanuary 24, 2025 | markets.businessinsider.comValneva Reports Positive Trial Results for Pediatric Chikungunya VaccineJanuary 23, 2025 | tipranks.comHC Wainwright Lowers Valneva (NASDAQ:VALN) Price Target to $18.00HC Wainwright decreased their price target on Valneva from $19.00 to $18.00 and set a "buy" rating on the stock in a research note on Thursday.January 23, 2025 | marketbeat.comValneva reports Phase 2 results in children for its chikungunya vaccineJanuary 23, 2025 | msn.comValneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose DecisionJanuary 22, 2025 | globenewswire.comValneva gains after new Phase 3 data for chikungunya vaccine in adolescentsJanuary 21, 2025 | msn.comValneva announces positive outcomes from chikungunya vaccine trialJanuary 21, 2025 | msn.comValneva’s Chikungunya Vaccine Shows Promising Results in AdolescentsJanuary 21, 2025 | tipranks.comValneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya VaccineJanuary 20, 2025 | globenewswire.comValneva SE (NASDAQ:VALN) Short Interest Down 34.6% in DecemberValneva SE (NASDAQ:VALN - Get Free Report) was the target of a large decrease in short interest in December. As of December 31st, there was short interest totalling 15,900 shares, a decrease of 34.6% from the December 15th total of 24,300 shares. Based on an average daily volume of 38,300 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.0% of the company's shares are sold short.January 14, 2025 | marketbeat.comValneva to Meet with Investors during the J.P. Morgan Healthcare ConferenceJanuary 6, 2025 | globenewswire.comValneva SE (NASDAQ:VALN) Short Interest UpdateValneva SE (NASDAQ:VALN - Get Free Report) saw a large decrease in short interest in December. As of December 15th, there was short interest totalling 24,300 shares, a decrease of 20.6% from the November 30th total of 30,600 shares. Based on an average daily volume of 30,000 shares, the short-interest ratio is currently 0.8 days. Approximately 0.0% of the company's shares are short sold.December 29, 2024 | marketbeat.comExploring High Growth Tech Stocks for December 2024December 23, 2024 | finance.yahoo.comHealth Talk: Why an India-made Chikungunya vaccine is good newsDecember 21, 2024 | msn.comSII to manufacture French firm’s vaccine for chikungunyaDecember 20, 2024 | msn.comValneva and Serum Institute of India Collaborate to Tackle Chikungunya in AsiaDecember 19, 2024 | markets.businessinsider.comSerum Institute of India to manufacture French company Valneva’s Chikungunya vaccineDecember 19, 2024 | msn.com Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address VALN Media Mentions By Week VALN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VALN News Sentiment▼0.120.60▲Average Medical News Sentiment VALN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VALN Articles This Week▼144▲VALN Articles Average Week Get Valneva News Delivered to You Automatically Sign up to receive the latest news and ratings for VALN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TARS News JANX News AGIO News NAMS News IDYA News SDGR News TVTX News BLTE News VERA News IOVA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VALN) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valneva SE Please log in to your account or sign up in order to add this asset to your watchlist. Share Valneva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
